Community/Retail

The deaths this week of Kate Spade and Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented.

As one of the most accessible health care providers, our patients come to us seeking advice not only for prescription medication and OTC questions but also on the big question: "How do I get healthy?"

An esteemed panel will deliberate more than 600 nominations.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Half of people who have diabetes eventually develop diabetic peripheral neuropathy, and the warning signs are sensory symptoms that start in the distant periphery and progressing in a characteristic 'glove and stocking' way.

As the 2018 midterm elections approach and the 115th Congress draws to a close, it is important for pharmacists to stay informed on legislative and regulatory issues that have the potential to affect their practice.

Point-of-care testing (POTC) increase patients' access to care and treatment. In 2 areas—influenza and streptococcal pharyngitis—POCT is available, but not used as often as it could be.

Kidney disease occurs along a continuum, and for people who have diabetes, the risk of developing kidney disease is significantly elevated.

In this clip, Mark Neuenschwander, President of The Neuenschwander Company, explains the role that automation and technology plays in health care, and how it will affect the future of pharmacy practice.

Should emergency room clinicians use a breath-actuated nebulizer (BAN) or is a metered-dose inhaler (MDI) a better choice?

In this clip, Mark Neuenschwander, President of The Neuenschwander Company, discussed IV preparation errors and the importance of workflow technologies in reducing error rates.

Patricia C. Kienle, BSPharm, MPA, FASHP, director of accreditation and medication safety at Cardinal Health Innovative Delivery Solutions, discusses the impact of IV drug shortages and the importance of preparing for these shortages.

Fred Massoomi, PharmD, FASHP, Senior Director at Visante, explains how USP 800 regulations will drive the use of closed system transfer devices in health care.

Drug shortages aren’t going away anytime soon, which is why it’s important for pharmacies to put preparedness plans in place ahead of future IV shortages, according to an interactive discussion held this week at the ASHP Summer Meeting and Exhibition.

Leticia Shea, PharmD, BCACP, Associate Professor of Pharmacy at Regis University, discusses why it's important for pharmacists to stay up-to-date on the latest laws and research surrounding medical marijuana use.

Joshua Evans, PhD, assistant professor of health care ethics at Regis University, discusses some of the common ethical dilemmas associated with medical marijuana.

Fred Massoomi, PharmD, FASHP, senior director for Visante, discusses using closed system transfer devices.

Officials with the FDA have approved Lannett Company’s Levofloxacin Oral Solution.

The latest teen drug use survey reveals that use of vaping devices and e-liquids have increased.

In this clip, Fred Massoomi, PharmD, FASHP, Senior Director at Visante, offers advice on the best practices for USP 800 compliance, including gap analysis, individual monitoring, and education.

The FDA has approved pegfilgrastim-jmdb (Fulphila, Mylan GmbH) as the first biosimilar to pegfilgrastim (Neulasta) to help reduce the chance of fever-causing infection for a population of patients with cancer.

A pharmacy that truly differentiates itself may create a niche that the giant online retailer would have trouble encroaching upon.

For health care providers, staying up to date on drug development trends is crucial to understanding the implications of these therapies and how they can best help their patients.

An emerging area of investigation in asthma and chronic obstructive pulmonary disease is use of statins.

Combining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non–small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.

In this clip, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, compares the use of premixed with compound IV products for enhanced patient safety.

The new section will provide an enhanced focus on ASHP’s efforts to help its members provide optimal patient care and comprehensive medication therapy management in the specialty pharmacy environment.

Pharmacists have a crucial role to play in identifying medication safety issues and implementing best practices to prevent errors, according to the ISMP.